| scholarly article | Q13442814 |
| P2093 | author name string | Jing Li | |
| Xiaohong Li | |||
| Qianqian Zhang | |||
| Qunyi Guo | |||
| Wenda Luo | |||
| Yanping Shao | |||
| P2860 | cites work | Nanocarriers as an emerging platform for cancer therapy | Q29616699 |
| P-gp activity is a critical resistance factor against AVE9633 and DM4 cytotoxicity in leukaemia cell lines, but not a major mechanism of chemoresistance in cells from acute myeloid leukaemia patients | Q33472987 | ||
| Chronic myelogenous leukemia: update on biology and treatment | Q33541576 | ||
| Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology | Q51346548 | ||
| Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo | Q51533655 | ||
| Anticancer activity of gallic acid template-based benzylidene indanone derivative as microtubule destabilizer | Q51591741 | ||
| Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy | Q51738437 | ||
| Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy. | Q55027038 | ||
| Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity | Q57483617 | ||
| Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery | Q58613564 | ||
| Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib. | Q64886353 | ||
| Hyaluronan receptor (CD44) expression and function in human peripheral blood monocytes and alveolar macrophages | Q71657172 | ||
| Coformulation of Doxorubicin and Curcumin in Poly(d,l-lactide-co-glycolide) Nanoparticles Suppresses the Development of Multidrug Resistance in K562 Cells | Q83824669 | ||
| Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin | Q88086664 | ||
| Gallic acid targets acute myeloid leukemia via Akt/mTOR-dependent mitochondrial respiration inhibition | Q89044458 | ||
| RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy | Q89391509 | ||
| Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line | Q35673292 | ||
| Ceramide and N,N,N-Trimethylphytosphingosine-Iodide (TMP-I)-Based Lipid Nanoparticles for Cancer Therapy. | Q35764089 | ||
| Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. | Q35771214 | ||
| Effective co-delivery of doxorubicin and dasatinib using a PEG-Fmoc nanocarrier for combination cancer chemotherapy | Q35998388 | ||
| Homoharringtonine delivered by high proportion PEG of long- circulating liposomes inhibits RPMI8226 multiple myeloma cells in vitro and in vivo | Q36878540 | ||
| Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform. | Q38069342 | ||
| Targeted nanoparticles for pediatric leukemia therapy | Q38214772 | ||
| Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer | Q38428931 | ||
| Polyethylene glycol-modified arachidyl chitosan-based nanoparticles for prolonged blood circulation of doxorubicin. | Q38442227 | ||
| Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation | Q38724286 | ||
| Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy | Q38798081 | ||
| Gallic acid enhancement of gold nanoparticle anticancer activity in cervical cancer cells | Q38914332 | ||
| Synergistic antitumor effects of doxorubicin-loaded carboxymethyl cellulose nanoparticle in combination with endostar for effective treatment of non-small-cell lung cancer | Q38993179 | ||
| A star-shaped porphyrin-arginine functionalized poly(L-lysine) copolymer for photo-enhanced drug and gene co-delivery | Q39020293 | ||
| Anti-leukemic effects of gallic acid on human leukemia K562 cells: Downregulation of COX-2, inhibition of BCR/ABL kinase and NF-κB inactivation | Q39412296 | ||
| In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer | Q39464914 | ||
| Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia | Q39754914 | ||
| Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier | Q39819856 | ||
| Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice | Q40246743 | ||
| Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells. | Q40314486 | ||
| Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer | Q41382500 | ||
| Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy | Q41383019 | ||
| Ca2+-Dependent caspase activation by gallic acid derivatives | Q43676621 | ||
| Encapsulation of Piper cabralanum (Piperaceae) nonpolar extract in poly(methyl methacrylate) by miniemulsion and evaluation of increase in the effectiveness of antileukemic activity in K562 cells | Q47161864 | ||
| Glutathione-Sensitive Hyaluronic Acid-Mercaptopurine Prodrug Linked via Carbonyl Vinyl Sulfide: A Robust and CD44-Targeted Nanomedicine for Leukemia | Q47761784 | ||
| Combination lung cancer chemotherapy: Design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalin | Q47783865 | ||
| Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy | Q49853553 | ||
| Charge Reversible and Mitochondria/Nucleus Dual Target Lipid Hybrid Nanoparticles To Enhance Antitumor Activity of Doxorubicin | Q50047512 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | nanotechnology | Q11468 |
| doxorubicin | Q18936 | ||
| P304 | page(s) | 2043-2055 | |
| P577 | publication date | 2019-06-28 | |
| P1433 | published in | Drug Design, Development and Therapy | Q2566724 |
| P1476 | title | In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid-polymeric hybrid nano-system for leukemia therapy | |
| P478 | volume | 13 |
| Q89895365 | Co-Encapsulation of Mitoxantrone and β-Elemene in Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Leukemia |
| Q90246950 | Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles |
| Q89939081 | Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles |
Search more.